408 related articles for article (PubMed ID: 25889094)
1. Altered balance of interleukin-13/interferon-gamma contributes to lacrimal gland destruction and secretory dysfunction in CD25 knockout model of Sjögren's syndrome.
Bian F; Barbosa FL; Corrales RM; Pelegrino FS; Volpe EA; Pflugfelder SC; de Paiva CS
Arthritis Res Ther; 2015 Mar; 17(1):53. PubMed ID: 25889094
[TBL] [Abstract][Full Text] [Related]
2. Deletion of interferon-γ delays onset and severity of dacryoadenitis in CD25KO mice.
Pelegrino FS; Volpe EA; Gandhi NB; Li DQ; Pflugfelder SC; de Paiva CS
Arthritis Res Ther; 2012 Nov; 14(6):R234. PubMed ID: 23116218
[TBL] [Abstract][Full Text] [Related]
3. Age-Related Conjunctival Disease in the C57BL/6.NOD-Aec1Aec2 Mouse Model of Sjögren Syndrome Develops Independent of Lacrimal Dysfunction.
You IC; Bian F; Volpe EA; de Paiva CS; Pflugfelder SC
Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2224-33. PubMed ID: 25758816
[TBL] [Abstract][Full Text] [Related]
4. Age-related T-cell cytokine profile parallels corneal disease severity in Sjogren's syndrome-like keratoconjunctivitis sicca in CD25KO mice.
De Paiva CS; Hwang CS; Pitcher JD; Pangelinan SB; Rahimy E; Chen W; Yoon KC; Farley WJ; Niederkorn JY; Stern ME; Li DQ; Pflugfelder SC
Rheumatology (Oxford); 2010 Feb; 49(2):246-58. PubMed ID: 20007286
[TBL] [Abstract][Full Text] [Related]
5. Interferon-γ treatment in vitro elicits some of the changes in cathepsin S and antigen presentation characteristic of lacrimal glands and corneas from the NOD mouse model of Sjögren's Syndrome.
Meng Z; Klinngam W; Edman MC; Hamm-Alvarez SF
PLoS One; 2017; 12(9):e0184781. PubMed ID: 28902875
[TBL] [Abstract][Full Text] [Related]
6. Destruction of salivary and lacrimal glands by Th1-polarized reaction in a model of secondary Sjögren's syndrome in lupus-prone female NZB × NZWF(1) mice.
Hayashi T; Shimoyama N; Mizuno T
Inflammation; 2012 Apr; 35(2):638-46. PubMed ID: 21786007
[TBL] [Abstract][Full Text] [Related]
7. Innate Immune Signaling Induces IL-7 Production, Early Inflammatory Responses, and Sjögren's-Like Dacryoadenitis in C57BL/6 Mice.
Zhou J; Jin JO; Du J; Yu Q
Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):7831-8. PubMed ID: 26658504
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Cathepsin S Reduces Lacrimal Gland Inflammation and Increases Tear Flow in a Mouse Model of Sjögren's Syndrome.
Klinngam W; Janga SR; Lee C; Ju Y; Yarber F; Shah M; Guo H; Wang D; MacKay JA; Edman MC; Hamm-Alvarez SF
Sci Rep; 2019 Jul; 9(1):9559. PubMed ID: 31267034
[TBL] [Abstract][Full Text] [Related]
9. Lacrimal gland fluid secretion and lymphocytic infiltration in the NZB/W mouse model of Sjögren's syndrome.
Paranyuk Y; Claros N; Birzgalis A; Moore LC; Brink PR; Walcott B
Curr Eye Res; 2001 Sep; 23(3):199-205. PubMed ID: 11803482
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological cholinergic blockade stimulates inflammatory cytokine production and lymphocytic infiltration in the mouse lacrimal gland.
Pitcher JD; De Paiva CS; Pelegrino FS; McClellan AJ; Raince JK; Pangelinan SB; Rahimy E; Farley WJ; Stern ME; Li DQ; Pflugfelder SC
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3221-7. PubMed ID: 21273534
[TBL] [Abstract][Full Text] [Related]
11. Differential cytokine expression and regulatory cells in patients with primary and secondary Sjögren's syndrome.
Furuzawa-Carballeda J; Sánchez-Guerrero J; Betanzos JL; Enriquez AB; Avila-Casado C; Llorente L; Hernández-Molina G
Scand J Immunol; 2014 Dec; 80(6):432-40. PubMed ID: 25346207
[TBL] [Abstract][Full Text] [Related]
12. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca.
Pflugfelder SC; Jones D; Ji Z; Afonso A; Monroy D
Curr Eye Res; 1999 Sep; 19(3):201-11. PubMed ID: 10487957
[TBL] [Abstract][Full Text] [Related]
13. Th1 versus Th2 immune responses in autoimmune lacrimal gland disease in MRL/Mp mice.
Jabs DA; Lee B; Whittum-Hudson JA; Prendergast RA
Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):826-31. PubMed ID: 10711700
[TBL] [Abstract][Full Text] [Related]
14. Time course of cytokine upregulation in the lacrimal gland and presence of autoantibodies in a predisposed mouse model of Sjögren's Syndrome: the influence of sex hormones and genetic background.
Czerwinski S; Mostafa S; Rowan VS; Azzarolo AM
Exp Eye Res; 2014 Nov; 128():15-22. PubMed ID: 25218176
[TBL] [Abstract][Full Text] [Related]
15. [The evaluation of chosen cytokines in induction of ocular changes in Sjögren's syndrome of dry eye].
Zywalewska-Górna N; Mrugacz M; Bakunowicz-Lazarczyk A
Klin Oczna; 2007; 109(10-12):435-7. PubMed ID: 18488390
[TBL] [Abstract][Full Text] [Related]
16. Rapamycin Eye Drops Suppress Lacrimal Gland Inflammation In a Murine Model of Sjögren's Syndrome.
Shah M; Edman MC; Reddy Janga S; Yarber F; Meng Z; Klinngam W; Bushman J; Ma T; Liu S; Louie S; Mehta A; Ding C; MacKay JA; Hamm-Alvarez SF
Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):372-385. PubMed ID: 28122086
[TBL] [Abstract][Full Text] [Related]
17. Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome.
Fox RI; Kang HI; Ando D; Abrams J; Pisa E
J Immunol; 1994 Jun; 152(11):5532-9. PubMed ID: 8189070
[TBL] [Abstract][Full Text] [Related]
18. Improvement of lacrimal function by topical application of CyA in murine models of Sjögren's syndrome.
Tsubota K; Fujita H; Tadano K; Takeuchi T; Murakami T; Saito I; Hayashi Y
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):101-10. PubMed ID: 11133854
[TBL] [Abstract][Full Text] [Related]
19. A case for IL-6, IL-17A, and nitric oxide in the pathophysiology of Sjögren's syndrome.
Benchabane S; Boudjelida A; Toumi R; Belguendouz H; Youinou P; Touil-Boukoffa C
Int J Immunopathol Pharmacol; 2016 Sep; 29(3):386-97. PubMed ID: 27207443
[TBL] [Abstract][Full Text] [Related]
20. Protective role of commensal bacteria in Sjögren Syndrome.
Zaheer M; Wang C; Bian F; Yu Z; Hernandez H; de Souza RG; Simmons KT; Schady D; Swennes AG; Pflugfelder SC; Britton RA; de Paiva CS
J Autoimmun; 2018 Sep; 93():45-56. PubMed ID: 29934134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
